Finance

Beta
Lists
300791:SHE
Sirio Pharma Co Ltd
CNÂ¥16.93
-0.94%
(-0.16) 1D
Jun 5, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300791...
Open
CNÂ¥17.09
High
CNÂ¥17.45
Low
CNÂ¥16.75
Mkt. cap
5.23B
Avg. vol.
1.99M
Volume
2.35M
Dividend
0.77%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
43.78
52-wk high
CNÂ¥28.19
52-wk low
CNÂ¥16.75
EPS
CNÂ¥0.39
Shares outstanding
308.69M
No. of employees
3K
Open
CNÂ¥17.09
High
CNÂ¥17.45
Low
CNÂ¥16.75
Mkt. cap
5.23B
Avg. vol.
1.99M
Volume
2.35M
Dividend
0.77%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
43.78
52-wk high
CNÂ¥28.19
52-wk low
CNÂ¥16.75
EPS
CNÂ¥0.39
Shares outstanding
308.69M
No. of employees
3K
News stories
From sources across the web
About Sirio Pharma Co Ltd
CEO-
Employees2.78K
FoundedAug 16, 1993
Headquarters-
SectorPersonal care products
Websitesiriopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.09B
1.25B
971.73M
1.00B
Cost of goods sold
728.94M
861.97M
813.57M
678.46M
Cost of revenue
728.94M
861.97M
813.57M
678.46M
Research and development expenses
33.06M
38.35M
45.42M
30.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
208.97M
215.84M
212.36M
194.40M
Operating expense
251.66M
257.90M
268.79M
231.64M
Total operating expenses
980.60M
1.12B
1.08B
910.10M
Operating income
106.81M
129.68M
-110.63M
93.23M
Other non operating income
-6.36M
-411.82K
3.74M
-19.46M
EBT including unusual items
83.69M
106.40M
-260.84M
51.78M
EBT excluding unusual items
82.06M
98.89M
-137.27M
56.01M
Income tax expense
3.92M
20.83M
-59.41M
9.86M
Effective tax rate
4.68%
19.58%
22.78%
19.03%
Other operating expenses
7.34M
893.72K
9.89M
3.95M
Net income
92.48M
99.15M
-123.74M
49.91M
Net profit margin
8.50%
7.93%
-12.73%
4.97%
Earnings per share
-
-
-
-
Interest and investment income
1.02M
1.48M
3.03M
1.40M
Interest expense
-24.56M
-26.72M
-27.07M
-19.16M
Net interest expenses
-23.54M
-25.23M
-24.04M
-17.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
157.93M
175.38M
-62.67M
-
Gain or loss from assets sale
218.73K
-218.73K
-2.43M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer